Stake sale
Unicorn India Ventures partly exits Sascan Meditech
By Startup Enthusiast ·
- Date
- Company
- Unicorn India Ventures
- What it does
- Unicorn India Ventures
- Kind
- Stake sale
- Based in
- Mumbai
What they do
The fund sold part of its holding in Thiruvananthapuram cancer-screening maker Sascan Meditech, earning about six times its money on the exit
What happened
It had put ₹2 crore into the company across two rounds, first in 2020 as its earliest institutional backer, then again in 2021
Why it matters
The fund keeps a sizeable stake, and Sascan's products include OralScan for oral cancer screening and CerviScan for cervical examination
The details
- Unicorn India Ventures made a partial exit (selling part of its stake) from Sascan Meditech.
- The exit returned about 6x the money to the fund.
- It had invested ₹2 crore over two rounds, in 2020 and 2021.
- The fund still holds a substantial stake in the company.
- Sascan was founded in 2015 by laser scientist Dr Subhash Narayanan.
More on Unicorn India Ventures
- Unicorn India Ventures and IIT Madras announce fund26 September 2026 · New fund · ₹450 Cr
- Unicorn India Ventures founder discusses early-stage investing and India's startup evolution20 February 2026 · Analysis
- IIT Madras and Unicorn India launch deeptech fund6 February 2026 · New fund · ₹600 Cr
- Unicorn India Ventures closes Fund III at ₹1,200 crore24 October 2025 · New fund · ₹1,200 Cr
- Unicorn India Ventures opens Fund III with ₹225 crore5 September 2023 · New fund · ₹225 Cr
- Unicorn India Ventures closes first tranche of Fund II30 March 2020 · New fund · ₹90 Cr